Blau is a leading pharmaceutical industry in the institutional segment and a pioneer in biotechnology, with a proprietary portfolio of highly complex medicines that serve the main therapeutic areas of the hospital products market. The Company is divided into 4 business units: Biotechnology, Oncology, Specialty and Others.
Our strategy is based on Operational Expansion - with the increase of the productive capacity -, Verticalization of the production chain - with the production of biotechnological active pharmaceutical ingredients (API) -, Development of new products - with a strong investment in RD&I and in Business Development - and M&A and Internationalization - with the expansion of new registrations in Latin America and the expansion of the portfolio through strategic partnerships. See more.
Follow the main moments of the more than 34 years of Blau's history. See more.